반응식
[CH:1]1[CH:2]=[CH:3][C:4]2[N:15]([C:16]([NH2:18])=[O:17])[C:14]3[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=3[CH:8]=[CH:7][C:5]=2[CH:6]=1.[NH2:19][C:20]1[CH:28]=[CH:27][C:23]([C:24]([OH:26])=[O:25])=[CH:22][CH:21]=1>CO>[CH:11]1[CH:12]=[CH:13][C:14]2[N:15]([C:16]([NH2:18])=[O:17])[C:4]3[CH:3]=[CH:2][CH:1]=[CH:6][C:5]=3[CH:7]=[CH:8][C:9]=2[CH:10]=1.[NH2:19][C:20]1[CH:28]=[CH:27][C:23]([C:24]([OH:26])=[O:25])=[CH:22][CH:21]=1참가 물질
4
실험 절차
40 mg (0.1693 mmol) of carbamazepine and 30 mg (0.1421 mmol) of 4-aminobenzoic acid were dissolved in approximately 3 mL methanol. Slow evaporation of the solvent yielded clear plates of carbamazepine:4-aminobenzoic acid (2:1) co-crystal. The co-crystal was analyzed via IR spectroscopy and single-crystal x-ray diffraction.
후처리
- customevaporation of the solvent
출처 및 근거
- ORD 기록
- ord-44bb3b9cb73747d187051a5a3f9e2af5
- 출처 데이터셋
- uspto-grants-2010_09
- 특허 번호
- US07803786B2
연결된 노트
불러오는 중…